Kliničke studije za Lupus u državi Oklahoma
8 studija za Lupus traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50262, Oklahoma City
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Oklahoma Medical Research Foundation, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07409181A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Oklahoma City
- Research Site, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07430306A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- Oklahoma Medical Research Foundation, Oklahoma City
U tijeku regrutacijaFaza 4
Od 18 do 75 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Oklahoma Medical Research Foundation, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 16 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Oklahoma Medical Research Foundation, Oklahoma City
U tijeku regrutacijaFaza 3
Od 55 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Oklahoma, Oklahoma City
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Safety of the Herpes Zoster Subunit Vaccine in Lupus
- Oklahoma Medical Research Foundation, Oklahoma City
U tijeku regrutacijaFaza 4
Od 18 do 90 godina · Oba spola · Ažurirano 26. pro 2025. · NCT05559671Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.